Federal Register Notice: FDA is sponsoring a public hearing 5/11 to obtain input on recently issued draft guidances on developing biosimilar products issued as part of the implementation of the Biologics Price Competition and Innovation Act of 2009. The agency will consider information from the hearing in finalizing the guidances. It also seeks public input on topics for future biosimilar policies. The hearing will be held from 8:30 a.m. to 5 p.m. at FDA's White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503, Silver Spring, MD. Contact Sandra J. Benton, (301) 796-1042. To view this notice, click here.